Tamsulosin Hydrochloride
Product Images NDC 53808-0691

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 53808-0691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 0.4mg (Tamsulosin HCl 0.4mg)

Label for Tamsulosin Hydrochloride 0.4 mg capsules, quantity 60, from State of Florida DOH Central Pharmacy in Tallahassee, FL 32304. The label includes lot number MM8435, an expiration date of 07/31/2013, and a UPC barcode.*

FDA Label Image

Structured Formula For Tamsulosin (Tamsulosinhydrochloride1 Figure 01)

Chemical structure of Tamsulosin Hydrochloride, displaying its molecular arrangement with aromatic rings, methoxy and sulfonamide groups, and HCl salt form.*

FDA Label Image

Structured Formula For Tamsulosin (Tamsulosinhydrochloride1 Figure 02)

A line graph showing plasma concentration (mg/mL) over time (hours) comparing Tamsulosin Hydrochloride under fasting and fed conditions. The graph plots two curves indicating variation in absorption dynamics between the two states.*

FDA Label Image

Structured Formula For Tamsulosin (Tamsulosinhydrochloride1 Figure 03)

A line graph showing mean change over 13 weeks by duration of treatment for Tamsulosin Hydrochloride at doses 0.4 mg and 0.8 mg compared to placebo. The x-axis represents weeks of treatment, and the y-axis represents mean change. The graph includes sample size at each time point and distinguishes the treatment groups with different markers.*

FDA Label Image

Structured Formula For Tamsulosin (Tamsulosinhydrochloride1 Figure 04)

A line graph depicting mean change over the duration of treatment in weeks for three groups: Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo. The x-axis shows treatment duration from 0 to 13 weeks and LOCF (last observation carried forward), while the y-axis shows mean change values. Data points include sample sizes at different weeks. The figure compares the effects of the two Tamsulosin doses versus placebo over time.*

FDA Label Image

Structured Formula For Tamsulosin (Tamsulosinhydrochloride1 Figure 05)

A line graph depicting mean change in a measured variable (mL/sec) over duration of treatment in weeks, comparing three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis shows time points from baseline (B) through 14 weeks including a last observation carried forward (LOCF) measure, and the y-axis represents mean change values ranging from 0 to 3. Sample sizes at each time point are noted below the x-axis.*

FDA Label Image

Structured Formula For Tamsulosin (Tamsulosinhydrochloride1 Figure 06)

A line graph showing mean change in measurement (mL/sec) over duration of treatment in weeks. The graph compares three treatments: 0.8 mg, 0.4 mg, and placebo. Treatment groups are represented with different symbols: circles for 0.8 mg, triangles for 0.4 mg, and squares for placebo, with participant numbers noted below each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.